MedPath

Effectiveness of exercise in Systemic Lupus Erythematosus.

Not Applicable
Recruiting
Conditions
Systemic Lupus Erythematosus
Inflammatory and Immune System - Autoimmune diseases
Registration Number
ACTRN12621000970842
Lead Sponsor
niversity of Southern Queensland
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Adults (18+)

Diagnosis of systemic lupus erythematosus by the classification criteria ACR and the 2019 EULAR Classification Criteria for systemic lupus erythematosus.

Complete a self-created screening questionnaire by the principle investigator, as well as the Exercise & Sports Science Australia (ESSA) adult-pre-screening tool and be stratified as low-moderate risk. If they are deemed to be moderate-high risk, more information may need to be sought from their regular treating physician to determine their eligibility for inclusion. The principal investigator, Stephanie Frade, who is an Accredited Exercise Physiologist will be completing the screening with all participants over the phone, and will deem whether they are eligible and safe to complete the exercise program.

Exclusion Criteria

•Currently pregnant. This will be informed by a self-created screening tool that will be completed by the principle investigator over the phone prior to commencing their baseline assessment.
•Absolute contraindications including: Active lupus nephritis, myocarditis, or pericarditis. This will be informed by a self-created screening tool that will be completed by the principle investigator over the phone prior to commencing their baseline assessment.
•Relative contraindications. This will be informed by a self-created screening tool and Exercise & Sports Science Australia screening tool that will be completed by the principle investigator over the phone prior to commencing their baseline assessment.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath